Volume 20, Number 9—September 2014
CME ACTIVITY - Research
Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
Table 2
Characteristic |
AIDS patients, n = 223 |
Non-AIDS patients, n = 321 |
p value |
---|---|---|---|
Days from admission to treatment initiation, median (IQR) | 1 (0–2) | 2 (0–6) | <0.0001 |
Intensive care admission | 65 (35) | 134 (50) | 0.0015 |
Immediate oxygen needed | 87 (49) | 160 (69) | <0.0001 |
Oxygen flow rate, L/min, mean (95% CI) |
2 (1.3–2.8) |
3.8 (2.8–4.8) |
0.015 |
Mechanical ventilation | |||
Noninvasive needed | 17 (8) | 50 (16) | 0.0053 |
Noninvasive failed | 16 (8) | 46 (15) | 0.013 |
Invasive needed |
25 (11.0) |
98 (30.5) |
<0.0001 |
Hospital deaths | 8 (4) | 75 (27) | <0.0001 |
*Values are no. (%) patients except as indicated. PCP, Pneumocystis jirovecii pneumonia; IQR, interquartile range.
1Deceased.
Page created: August 14, 2014
Page updated: August 14, 2014
Page reviewed: August 14, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.